{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T05:14:12Z","timestamp":1649049252511},"reference-count":21,"publisher":"Edizioni Minerva Medica","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ital J Dermatol Venereol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.23736\/s2784-8671.20.06623-7","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T22:10:38Z","timestamp":1633644638000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of certolizumab pegol in na\u00efve versus multi-treated patients affected by psoriatic arthritis"],"prefix":"10.23736","volume":"156","author":[{"given":"Annunziata","family":"DATTOLA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"VOLLONO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria V.","family":"CANNIZZARO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele D.","family":"CAPOSIENA CARO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"MAZZILLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"MELINO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"CANDI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"CAMPIONE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"BIANCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17149","reference":[{"key":"10.23736\/S2784-8671.20.06623-7_ref001","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1139453"},{"key":"10.23736\/S2784-8671.20.06623-7_ref002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1704342"},{"key":"10.23736\/S2784-8671.20.06623-7_ref003","first-page":"518","article-title":"Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid","volume":"24","author":"Partsch G","year":"1997","journal-title":"J Rheumatol"},{"key":"10.23736\/S2784-8671.20.06623-7_ref004","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg384"},{"key":"10.23736\/S2784-8671.20.06623-7_ref005","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S162420"},{"key":"10.23736\/S2784-8671.20.06623-7_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2006.06.010"},{"key":"10.23736\/S2784-8671.20.06623-7_ref007","first-page":"313","article-title":"Role of Th17 in the pathogenesis of cutaneous inflammatory diseases","volume":"26","author":"Chiricozzi A","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.23736\/S2784-8671.20.06623-7_ref008","first-page":"165","article-title":"New insights into the pathogenesis of cutaneous autoimmune disorders","volume":"26","author":"Chiricozzi A","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.23736\/S2784-8671.20.06623-7_ref009","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208337"},{"key":"10.23736\/S2784-8671.20.06623-7_ref010","doi-asserted-by":"publisher","DOI":"10.1002\/art.39573"},{"key":"10.23736\/S2784-8671.20.06623-7_ref011","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13354"},{"key":"10.23736\/S2784-8671.20.06623-7_ref012","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-013-0064-z"},{"key":"10.23736\/S2784-8671.20.06623-7_ref013","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S31658"},{"key":"10.23736\/S2784-8671.20.06623-7_ref014","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212196"},{"key":"10.23736\/S2784-8671.20.06623-7_ref015","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211384"},{"key":"10.23736\/S2784-8671.20.06623-7_ref016","unstructured":"UCB Biopharma S.P.R.L. Dermira, Inc. An efficacy and safety study of two dose levels of certolizumab pegol (CZP) in subjects with plaque psoriasis (PSO) (CIMPASI-1); 2020 [Internet]. Available from: https:\/\/clinicaltrials.gov\/show\/NCT02326298 [cited 2021, Jul 22]."},{"key":"10.23736\/S2784-8671.20.06623-7_ref017","unstructured":"UCB Biopharma S.P.R.L. Dermira, Inc. A study to evaluate the efficacy and safety of two dose levels of certolizumab pegol (CZP) in subjects with plaque psoriasis (PSO) (CIMPASI-2); 2020[Internet]. Available from https:\/\/clinicaltrials.gov\/show\/NCT02326272 [cited 2021, Jul 22]."},{"key":"10.23736\/S2784-8671.20.06623-7_ref018","unstructured":"UCB Biopharma S.P.R.L. Dermira, Inc. Efficacy and safety study of certolizumab pegol (CZP) versus active comparator and placebo in subjects with plaque psoriasis (PSO) (CIMPACT); 2020 [Internet]. Available from https:\/\/clinicaltrials.gov\/show\/NCT02346240 [cited 2021, Jul 22]."},{"key":"10.23736\/S2784-8671.20.06623-7_ref019","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0208-z"},{"key":"10.23736\/S2784-8671.20.06623-7_ref020","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14114"},{"key":"10.23736\/S2784-8671.20.06623-7_ref021","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13409"}],"container-title":["Italian Journal of Dermatology and Venereology"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R23Y2021N04A0434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T22:11:39Z","timestamp":1633644699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R23Y2021N04A0434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":21,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.23736\/s2784-8671.20.06623-7","relation":{},"ISSN":["2784-8671","2784-8450"],"issn-type":[{"value":"2784-8671","type":"print"},{"value":"2784-8450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}